[Federal Register Volume 80, Number 59 (Friday, March 27, 2015)]
[Notices]
[Pages 16397-16398]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-07036]
[[Page 16397]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-15-15UR; Docket No. CDC-2015-0010]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing efforts to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies to take this opportunity to comment on proposed and/or
continuing information collections, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on newly proposed
information collection activities for enhanced surveillance of
Coccidioidomycosis in low- and non-endemic states.
DATES: Written comments must be received on or before May 26, 2015.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2015-
0010 by any of the following methods:
Federal eRulemaking Portal: Regulation.gov. Follow the
instructions for submitting comments.
Mail: Leroy A. Richardson, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE., MS-D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. All relevant comments received will be posted
without change to Regulations.gov, including any personal information
provided. For access to the docket to read background documents or
comments received, go to Regulations.gov.
Please note: All public comment should be submitted through the
Federal eRulemaking portal (Regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact the Information Collection Review Office,
Centers for Disease Control and Prevention, 1600 Clifton Road NE., MS-
D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email: [email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; (d) ways to
minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology; and (e) estimates of capital or start-
up costs and costs of operation, maintenance, and purchase of services
to provide information. Burden means the total time, effort, or
financial resources expended by persons to generate, maintain, retain,
disclose or provide information to or for a Federal agency. This
includes the time needed to review instructions; to develop, acquire,
install and utilize technology and systems for the purpose of
collecting, validating and verifying information, processing and
maintaining information, and disclosing and providing information; to
train personnel and to be able to respond to a collection of
information, to search data sources, to complete and review the
collection of information; and to transmit or otherwise disclose the
information.
Proposed Project
Enhanced Surveillance of Coccidioidomycosis in Low- and Non-Endemic
States--New--National Center for Emerging and Zoonotic Infectious
Diseases (NCEZID), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
Coccidioidomycosis, also called ``Valley fever,'' is a nationally
notifiable fungal infection caused by inhalation of soil-dwelling
Coccidioides spp. In the United States, coccidioidomycosis is known to
be endemic in the southwestern states, but new evidence suggests that
the true endemic areas may be broader than previously recognized.
Approximately 10,000 coccidioidomycosis cases are reported in the U.S.
each year to the National Notifiable Disease Surveillance System
(NNDSS), but this system captures limited clinical and epidemiological
information about reported cases. Most cases occur in Arizona or
California, so the epidemiology of this disease has been well-described
for these states, but little is known about the features of cases in
other states.
Enhanced surveillance in low- and non-endemic states will help
determine which information is most important to collect during routine
surveillance and will help assess the suitability of the Council of
State and Territorial Epidemiologists (CSTE) case definition for
coccidioidomycosis in these areas. Primary prevention strategies for
coccidioidomycosis have not yet been proven to be effective, so public
health efforts may be best aimed at promoting awareness of
coccidioidomycosis among healthcare providers and the general public.
Improved surveillance data are essential for identifying such
opportunities to promote awareness about this disease and for
determining its true public health burden.
For a period of one year, state health department personnel in
participating low- and non-endemic states (Louisiana, Michigan,
Minnesota, Missouri, Montana, Nevada, New Mexico, North Dakota, Ohio,
Oregon, Pennsylvania, Utah, and Wyoming) will conduct telephone
interviews with reported coccidioidomycosis cases that meet the CSTE
case definition and will record responses on a standardized form.
Information collected on the form will include demographics, underlying
medical conditions, travel history, symptom type and duration,
healthcare-seeking behaviors, diagnosis, treatment, and outcomes.
This interview activity is consistent with the state's existing
authority to investigate reports of notifiable diseases for routine
surveillance purposes; therefore, formal consent to participate in the
surveillance is not required. However, cases may choose not to
participate and may choose not to answer any question they do not wish
to answer.
[[Page 16398]]
It will take state health department personnel 20 minutes to
administer the questionnaire and 10 minutes to retrieve and record the
diagnostic information from their state reportable disease database.
Participation is voluntary. There are no costs to the respondents
other than their time. The total burden hours are 73 hours.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response Total burden
respondents respondent (in hrs.) (in hrs.)
----------------------------------------------------------------------------------------------------------------
State Health Department Case Report Form 145 1 30/60 73
Personnel. for
Coccidioidomyco
sis (Valley
Fever) Enhanced
Surveillance.
---------------------------------------------------------------------------------
Total..................... ................ .............. .............. .............. 73
----------------------------------------------------------------------------------------------------------------
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2015-07036 Filed 3-26-15; 8:45 am]
BILLING CODE 4163-18-P